Skip to content

Effectiveness of a Walking Intervention on Impact Loading and Pain

Effectiveness of a Walking Intervention on Impact Loading and Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04148807
Enrollment
40
Registered
2019-11-04
Start date
2019-11-05
Completion date
2023-03-30
Last updated
2022-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Pain Chronic, Osteoarthritis, Knee

Brief summary

This study investigates the feasibility of a gait-retraining program for older adults with knee osteoarthritis. The study will enroll 40 participants, with 20 receiving a gait retraining intervention and 20 receiving a graded walking program without gait retraining.

Detailed description

Knee osteoarthritis (OA) is a chronic condition affecting \ 12% of older adults in the United States and is a leading cause of disability. Knee pain is a common clinical manifestation that leads individuals with OA to seek medical care. Current rehabilitation approaches (e.g., bracing, taping, foot orthoses, strengthening, etc.) aim to reduce knee joint loading, a well-accepted risk factor for knee OA and pain, but are not always effective. Altering gait mechanics to reduce knee loading has also been suggested. Gait retraining studies for individuals with knee OA have focused on increasing trunk lean and toe out angle to reduce the knee adduction moment (a surrogate measure of joint loading). However, these strategies create an abnormal gait pattern and may not be the best long-term solutions due to the potential injury to other joints which may limit their overall effectiveness and applicability to clinical practice. Impact loading, another mechanical factor related to knee OA, has been reduced using gait retraining strategies in runners with knee pain. It is unknown if gait retraining strategies to decrease impact loading can reduce symptoms of knee OA. Thus, the purpose of this study is to determine the feasibility of a gait retraining program focusing on decreasing impact loading in individuals with knee OA. At baseline, following 8 intervention sessions, and at 1-month follow-up, participants will complete questionnaires, undergo three-dimensional gait analysis, and assessment of pressure pain threshold. Note: For participants enrolled during COVID-19 outbreak, only questionnaires will be collected at follow-up assessments.

Interventions

BEHAVIORALProgressive Walking with Gait Retraining

A progressive walking program with gait retraining will be performed on a treadmill at self-selected comfortable walking speed wearing an inertial measurement unit (IMU) on the medial aspect of the distal tibia. The (vertical) peak positive acceleration (PPA) of the tibia is a measure of tibial shock. Subjects will be provided real-time audio feedback to reduce PPA by 20% of their average peak PPA. During retraining sessions, a faded feedback approach will be used. Feedback will be provided continuously during the first four sessions and will be faded over the last 4 sessions. Walking time will increase over the 8 sessions.

A progressive walking program will also be performed on a treadmill where subjects will walk at a self-selected comfortable speed with the same walking times per session as the retraining group without any feedback or retraining cues.

Sponsors

Northeastern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects with a clinical definition of knee OA using NICE guidelines: * Age ≥ 45 * Walking related joint pain in the last week that averages ≥ 4 on 11-point numeric rating scale, where 0 = no pain and 10 = worst pain possible * History of knee pain for at least 3 months * Morning stiffness in the morning lasting less than 30 minutes

Exclusion criteria

* Walk with an assistive device * Current use of oral opiates or centrally acting pain medications * History of lower extremity surgery * Underwent an intra-articular knee joint injection in the past 3 months * Suffer from inflammatory arthritis or other conditions that affect lower extremity functions * Currently receiving treatment for their knee and unwilling to stop this treatment for the duration of the study * Currently pregnant * Skin allergies to adhesives

Design outcomes

Primary

MeasureTime frameDescription
Recruitment ratethrough study completion, an average of 2 years\# of participants screened per month
Enrollment ratethrough study completion, an average of 2 years\# of participants enrolled per month
Retentionthrough study completion, an average of 2 years% participants that complete all study visits

Secondary

MeasureTime frameDescription
Vertical instantaneous loading rateChange from baseline to conclusion of intervention, an average of 1-monthMaximum slope of the most vertical portion of the vertical ground reaction force curve between successive data points, during early stance.
Knee Pain with ActivitiesChange from baseline to conclusion of intervention, an average of 1-monthWOMAC questionnaire, pain sub scale 0-20
Withdrawals/Terminatedthrough study completion, an average of 2 yearsProportion of participants who withdraw or terminated by investigators and reasons why
Pressure pain thresholdChange from baseline to conclusion of intervention, an average of 1-monthAssessed using hand held algometer
Knee Pain SeverityChange from baseline to conclusion of intervention, an average of 1-monthVisual analog scale, 0-100
Adverse events (AE)/Unanticipated problems (UP)through study completion, an average of 2 yearsProportion of participants with AE/UP
Vertical average loading rateChange from baseline to conclusion of intervention, an average of 1-monthSlope of the most linear portion of the vertical ground reaction force curve, during early stance.

Countries

United States

Contacts

Primary ContactJoshua Stefanik, MSPT, PhD
j.stefanik@northeastern.edu6173738934

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026